SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-052941
Filing Date
2022-04-29
Accepted
2022-04-29 08:47:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2213667d3_defa14a.htm DEFA14A 12176
2 GRAPHIC tm2213667d3_defa14aimg001.jpg GRAPHIC 153087
3 GRAPHIC tm2213667d3_defa14aimg002.jpg GRAPHIC 93736
  Complete submission text file 0001104659-22-052941.txt   353370
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38128 | Film No.: 22870530
SIC: 2834 Pharmaceutical Preparations